Welcome to isctr.org
ISCTR in 2018
Welcome to 2018! With the new year upon us, ISCTR looks forward to exploring new initiatives in cardiovascular translation medicine and research that will benefit patients, clinicians, government, and industry alike — and we hope you will join us in these endeavors.
We are able to look to 2018 with enthusiasm thanks to a very successful 2017. More than 500 of you joined us in Denver in October at TCT 2017 for our Consensus Summit on Clinical Endpoints/Surrogates and Effect Size for Approval of Cardiovascular Devices. As you can see from the photos below, audience members engaged with our dynamic speakers throughout the day and feedback was overwhelming positive for the summit as a whole. We appreciate not only your participation but also that of a number of dedicated partners from academia, industry, and more who support ISCTR through our symposia and more. Please join us in thanking our sponsors for their support over this past year.
As working groups are being convened, ISCTR is in the process of creating a consensus document on the summit topic of clinical endpoints, which will accompany the consensus document on methods (the focus of our TCT 2016 summit) that is nearing completion. If you missed any of the presentations from our Denver summit, you will find video from all sessions here. These include the keynote address from Sir Professor Magdi Yacoub, MD, FRS, OM, the 2017 recipient of the Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Medicine.
As we enter the new year, we are excited about the first of several milestones we expect to reach: ISCTR’s online certification course on the translational pathway for device development, crafted in collaboration with the University of Arizona College of Medicine. The course will be active soon and further information on this new learning opportunity will be posted on this site before the course goes live.
Check back for frequent updates on these and other programs and activities. Thank you for starting your 2018 with ISCTR!
Mission and Goals of ISCTR
ESC Congress 2018
Join ISCTR at ESC.18 in Munich for a new symposium on Cardiovascular Translational Research. Check back here for details.
Become an ISCTR Member
An ISCTR member publication
International Society for
Cardiovascular Translational Research
The International Society for Cardiovascular Translational Research (ISCTR) is a non-profit organization that was founded in 2007 by Dr Nabil Dib with a goal to expedite scientific discovery to clinical application (patients).